Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child
Additional material online
This article includes two additional videos. You will find this supplemental at dx.doi.org/10.1007/s00059-012-3738-2
Patent ductus arteriosus (PDA) is one of the first congenital heart diseases to have been treated via the transcatheter technique. The first reported interventional closure was performed by Porstmann et al.  in 1971, followed by that of Rashkind and Cuaso. Since then, various devices have been used, such as the Gianturco coils, detachable coils, Flipper coils, Duct-Occlud coils, and Nit-Occlud coils. Over the last decade, clinical experience with transcatheter device closure of PDA has increased with various devices. In 1998, the Amplatzer duct occluder (ADO; AGA Medical Corp., MN, USA) was introduced, which has become the most frequently used device for closure of moderate to large PDAs. However, transcatheter closure of large PDAs with severe pulmonary hypertension still remains problematic. Treatment decision and device choice should be...
KeywordsPatent Ductus Arteriosus Severe Pulmonary Hypertension Transcatheter Closure Ventricular Systolic Pressure Amplatzer Duct Occluder
Verschluss eines großen persistierenden Ductus arteriosus mit schwerer pulmonaler Hypertonie über einen Katheter bei einem Kind
Conflict of interest
On behalf of all authors, the corresponding author states that there are no conflicts of interest.
Video 1: Parasternal short axis view of echo shows no residual shunting, good device position and no left pulmonary obstruction (QuickTime mov 330kb)
Video 2: Suprasternal view of echo shows good device position and no aortic obstructionvideo (QuickTime mov 190kb)
- 1.Porstmann W, Wierny L, Warnke H (1967) Der Verschluβ des Ductus arteriosus persistens ohne Thorakotomie (Vorflaufige, Mittelung). Thoraxchirurge 15:109–203Google Scholar